Jason Andrews

Dr. Arai has formal training in clinical research with a Masters in Epidemiology from Stanford University. She has a clinical practice seeing all diseases in hematopoietic cell transplantation, with a clinical research focus on the prevention and treatment of post-transplant complications.

Jeffrey Chi is a highly regarded clinical professor of medicine and hospitalist based in Palo Alto, CA, specializing in internal medicine. With a robust educational background from Yale School of Medicine and Stanford University, he has received numerous awards for excellence in teaching and research throughout his career. In addition to his clinical practice, Dr. Chi holds various administrative appointments and has contributed significantly to the academic community, including roles in medical education and hospital management. His research focuses on the functional responses of myeloid cell lines, highlighting his commitment to advancing medical knowledge and patient care. Generated from the website

My research has focused on rare, monogenetic skin diseases such as Epidermolysis Bullosa (EB) and Gorlin Syndrome (Basal Cell Nevus Syndrome). With my PhD training in basic science, post-doctoral fellowship in clinical research, and residency in dermatology, I am committed to improving the lives of EB patients, to correct their underlying genetic disease and to offer new treatments for their skin and esophageal wounds. I was the PI of the investigator-initiated, Phase 1/2A clinical trial of autologous gene-therapy skin grafts for RDEB (Pz-cel, EB-101, previously called LEAES).